Hepatitis C virus(HCV) which was originally recognized as posttransfusion non-A, non-B hepatitis has been amajor global health problem affecting 3% of the world
AIM To assess for passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts(TIPS) and compare outcomes with maximally dilated TI
AIM To examine patient-centered outcomes with vasopressin(AVP) use in patients with cirrhosis with catecholaminerefractory septic shock. METHODS We conducted a